http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102132221-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5db290e32b898d96dc1a2f0359fd3a23 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate | 2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_145182de649528b5bfdb386f357f963d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa75f7112ac13c682a78c1a8660f20a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d52b8aa6aa90b1e1e5b314bba53f42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3309350f43d50d0c6a24caf32b19515b |
| publicationDate | 2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102132221-B1 |
| titleOfInvention | Regulation mechanism of allergic reaction by miR-154-5p, and use thereof |
| abstract | The present invention relates to a mechanism for regulating an allergic reaction by miR-154-5p and its use, specifically measuring the expression level of miR-154-5p from a sample in order to provide information necessary for diagnosis of an allergic disease of a test subject Method, a pharmaceutical composition for preventing or treating allergic diseases containing an active inhibitor of miR-154-5p as an active ingredient, and a screening method for treating allergic diseases using a mechanism for controlling allergic reactions by miR-154-5p. According to the present invention, it is possible to effectively provide information necessary for the diagnosis of allergic diseases through a method of measuring the expression level of miR-154-5p, and the pharmaceutical composition according to the present invention containing an active inhibitor of miR-154-5p Using can effectively prevent or treat allergic diseases. In addition, it is expected that a method for screening a substance that reduces the expression of miR-154-5p can effectively search for a treatment for allergic diseases, and is expected to greatly contribute to the development of a new and more effective treatment for allergic diseases. |
| priorityDate | 2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.